Late‑Breaking Phase 2 Data on CD388 - Cidara Therapeutics to Present Influenza Prevention Findings a

Cidara will present late-breaking Phase 2 data on antiviral CD388 for prevention of influenza A and B on Oct 20, 2025 at ID Week; session 3:15-4:30 PM ET in Atlanta.

via: https://www.stocktitan.net/news/CDTX/cidara-therapeutics-to-present-late-breaking-clinical-phase-2-data-dm50nma19nu4.html